Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386895910> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4386895910 abstract "Purpose-Immunotherapy has revolutionized cancer therapy, becoming the standard of care for various malignancy treatments. Human immunodeficiency virus (HIV) patients, however, are an underserved group with limited access to clinical trials and cancer therapy. This study was to evaluate the safety and efficacy of programmed cell death 1 (PD - 1) inhibitors in patients with advanced cancer and HIV/acquired immunodeficiency syndrome (AIDS). Methods and Materials-We performed a prospective, open-label, nonrandomized, phase 1 single center study. Patients with advanced cancer and HIV/AIDS received the treatment of PD - 1 inhibitors (camrelizumab, 200 mg, administered intravenously every 3 weeks), along with combination antiretroviral therapy (cART) for HIV. Results-Sixteen participants (12 men and 4 women; median age, 46.5 (29 - 78) years) were enrolled; 1 had non - Hodgkin lymphoma (NHL), and 15 had non - AIDS - defining cancers. Safety was observed over 130 cycles of treatment with camrelizumab. Most treatment-emergent adverse events at least possibly attributed to camrelizumab were grade 1 or 2, including reactive cutaneous capillary endothelial proliferation (RCCEP) (9 participants), hearing loss (1 participant), hypophysitis (1 participant). 3 participants experienced hemorrhage due to poor performance status. HIV was controlled in all participants. Best tumor responses included 3 complete response, 5 partial response, 2 stable disease, and 6 progressive disease. The 2 years progression-free survival (PFS) was 67.0% (95% CI: -0.05, 0.00) and overall survival (OS) was 55.3% (95% CI: -0.05, 0.01) for the 16 patients who had received camrelizumab. Conclusions-This study demonstrates that camrelizumab treatment in patients with advanced cancers and HIV/AIDS was feasible and the clinical outcomes were acceptable." @default.
- W4386895910 created "2023-09-21" @default.
- W4386895910 creator A5044622075 @default.
- W4386895910 creator A5050498671 @default.
- W4386895910 creator A5050738451 @default.
- W4386895910 creator A5052476402 @default.
- W4386895910 creator A5062371490 @default.
- W4386895910 creator A5063789000 @default.
- W4386895910 creator A5073304157 @default.
- W4386895910 creator A5073304923 @default.
- W4386895910 creator A5084533999 @default.
- W4386895910 creator A5084751234 @default.
- W4386895910 creator A5091070290 @default.
- W4386895910 date "2023-09-19" @default.
- W4386895910 modified "2023-10-17" @default.
- W4386895910 title "The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China" @default.
- W4386895910 cites W2019607817 @default.
- W4386895910 cites W2514468425 @default.
- W4386895910 cites W2530620330 @default.
- W4386895910 cites W2789343266 @default.
- W4386895910 cites W2795698310 @default.
- W4386895910 cites W2899413762 @default.
- W4386895910 cites W2901185593 @default.
- W4386895910 cites W2908994384 @default.
- W4386895910 cites W2909046375 @default.
- W4386895910 cites W2909475651 @default.
- W4386895910 cites W2911264428 @default.
- W4386895910 cites W2911306684 @default.
- W4386895910 cites W2946456966 @default.
- W4386895910 cites W2946998144 @default.
- W4386895910 cites W2955805012 @default.
- W4386895910 cites W2982040065 @default.
- W4386895910 cites W2990137228 @default.
- W4386895910 cites W2999335564 @default.
- W4386895910 cites W3004098263 @default.
- W4386895910 cites W3005530155 @default.
- W4386895910 cites W3008514541 @default.
- W4386895910 cites W3012342269 @default.
- W4386895910 cites W3023736474 @default.
- W4386895910 cites W3025003676 @default.
- W4386895910 cites W3111665711 @default.
- W4386895910 cites W3138878330 @default.
- W4386895910 cites W3155149291 @default.
- W4386895910 cites W3206593389 @default.
- W4386895910 cites W4210431850 @default.
- W4386895910 cites W4210750489 @default.
- W4386895910 doi "https://doi.org/10.3389/fonc.2023.1248790" @default.
- W4386895910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37799470" @default.
- W4386895910 hasPublicationYear "2023" @default.
- W4386895910 type Work @default.
- W4386895910 citedByCount "0" @default.
- W4386895910 crossrefType "journal-article" @default.
- W4386895910 hasAuthorship W4386895910A5044622075 @default.
- W4386895910 hasAuthorship W4386895910A5050498671 @default.
- W4386895910 hasAuthorship W4386895910A5050738451 @default.
- W4386895910 hasAuthorship W4386895910A5052476402 @default.
- W4386895910 hasAuthorship W4386895910A5062371490 @default.
- W4386895910 hasAuthorship W4386895910A5063789000 @default.
- W4386895910 hasAuthorship W4386895910A5073304157 @default.
- W4386895910 hasAuthorship W4386895910A5073304923 @default.
- W4386895910 hasAuthorship W4386895910A5084533999 @default.
- W4386895910 hasAuthorship W4386895910A5084751234 @default.
- W4386895910 hasAuthorship W4386895910A5091070290 @default.
- W4386895910 hasBestOaLocation W43868959101 @default.
- W4386895910 hasConcept C121608353 @default.
- W4386895910 hasConcept C126322002 @default.
- W4386895910 hasConcept C143998085 @default.
- W4386895910 hasConcept C197934379 @default.
- W4386895910 hasConcept C2779399171 @default.
- W4386895910 hasConcept C535046627 @default.
- W4386895910 hasConcept C71924100 @default.
- W4386895910 hasConceptScore W4386895910C121608353 @default.
- W4386895910 hasConceptScore W4386895910C126322002 @default.
- W4386895910 hasConceptScore W4386895910C143998085 @default.
- W4386895910 hasConceptScore W4386895910C197934379 @default.
- W4386895910 hasConceptScore W4386895910C2779399171 @default.
- W4386895910 hasConceptScore W4386895910C535046627 @default.
- W4386895910 hasConceptScore W4386895910C71924100 @default.
- W4386895910 hasLocation W43868959101 @default.
- W4386895910 hasLocation W43868959102 @default.
- W4386895910 hasOpenAccess W4386895910 @default.
- W4386895910 hasPrimaryLocation W43868959101 @default.
- W4386895910 hasRelatedWork W1965152511 @default.
- W4386895910 hasRelatedWork W2091343103 @default.
- W4386895910 hasRelatedWork W2377100155 @default.
- W4386895910 hasRelatedWork W2403801615 @default.
- W4386895910 hasRelatedWork W2604014489 @default.
- W4386895910 hasRelatedWork W2793887421 @default.
- W4386895910 hasRelatedWork W3016698866 @default.
- W4386895910 hasRelatedWork W3153228984 @default.
- W4386895910 hasRelatedWork W4247453431 @default.
- W4386895910 hasRelatedWork W4312779314 @default.
- W4386895910 hasVolume "13" @default.
- W4386895910 isParatext "false" @default.
- W4386895910 isRetracted "false" @default.
- W4386895910 workType "article" @default.